← Open Payments lookup

MARK SKOUSEN: Open Payments

NPI 1013529155 · SNOWFLAKE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$829 in 36 payments from 9 companies in 2025. Trend: 2023 $165 · 2024 $202 · 2025 $829

Food & beverage: $717Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.13$307
Neurocrine BioSciences, Inc.5$112
Otsuka America Pharmaceutical, Inc.4$102
E.R. Squibb & Sons, L.L.C.4$83
Vanda Pharmaceuticals Inc.3$69
Alkermes, Inc.2$58
GlaxoSmithKline, LLC.2$39
Janssen Pharmaceuticals, Inc1$29
Supernus Pharmaceuticals, Inc.2$29

Products named: AUSTEDO XR, INGREZZA, ABILIFY MAINTENA, COBENFY, FANAPT, LYBALVI, TRELEGY ELLIPTA, INVEGA SUSTENNA.

Industry payments across AZ — which companies pay providers there.